Hon Wai Koon Selected Research

Hon Wai Koon Research Topics

Disease

12	Inflammation (Inflammations) 01/2022 - 10/2004
11	Colitis 01/2022 - 10/2004
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 11/2006
4	Fibrosis (Cirrhosis) 01/2022 - 11/2010
4	Pathologic Constriction (Stenosis) 01/2020 - 02/2012
3	Crohn Disease (Crohn's Disease) 01/2022 - 05/2017
3	Colonic Neoplasms (Colon Cancer) 03/2019 - 04/2007
2	Ulcerative Colitis 01/2020 - 05/2017
2	Clostridium Infections 01/2020 - 09/2013
2	Infections 01/2018 - 10/2016
2	Edema (Dropsy) 10/2016 - 08/2014
2	Enteritis 08/2014 - 09/2013
2	Diarrhea 11/2006 - 04/2005
1	Carcinoma (Carcinomatosis) 01/2022
1	Hyperalgesia 01/2022
1	Obesity 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Fatty Liver 01/2020
1	Hyperglycemia 01/2020
1	Neoplasm Metastasis (Metastasis) 03/2019
1	Colitis-Associated Neoplasms 03/2019
1	Autoimmune Diseases (Autoimmune Disease) 05/2017
1	Salmonella Infections (Salmonellosis) 01/2015
1	Neoplasms (Cancer) 01/2015
1	Reinfection 08/2014
1	Necrosis 09/2013
1	Ileitis 03/2013
1	Hypertension (High Blood Pressure) 01/2011

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 01/2022 - 11/2006
7	CathelicidinsIBA 03/2019 - 11/2011
5	CollagenIBA 01/2022 - 11/2010
5	Antimicrobial PeptidesIBA 01/2020 - 01/2013
4	ElafinIBA 01/2022 - 01/2013
4	Peptides (Polypeptides)IBA 01/2015 - 11/2006
4	Dextran SulfateIBA 01/2015 - 02/2011
4	NeuropeptidesIBA 02/2011 - 10/2004
3	Messenger RNA (mRNA)IBA 11/2017 - 01/2015
3	Substance PIBA 07/2015 - 11/2006
3	Clostridium difficile tcdA proteinIBA 08/2014 - 10/2004
3	NeurotensinIBA 02/2011 - 10/2004
2	PAR-2 ReceptorIBA 01/2022 - 01/2022
2	Sulfonic AcidsIBA 01/2022 - 11/2017
2	FidaxomicinIBA 01/2018 - 08/2014
2	Enterotoxins (Enterotoxin)IBA 09/2013 - 11/2006
2	Dextrans (Dextran)FDA Link 10/2012 - 02/2012
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2012 - 02/2012
2	ErbB Receptors (EGF Receptor)IBA 02/2011 - 04/2007
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 11/2010 - 11/2006
1	Protein Isoforms (Isoforms)IBA 01/2022
1	ArrestinIBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	Dynamin IIIBA 01/2022
1	Zinc Finger E-box-Binding Homeobox 1IBA 01/2022
1	methylmethacrylate-methacrylic acid copolymerIBA 01/2022
1	cathepsin SIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2020
1	LeptinIBA 01/2020
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	SteroidsIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	OP-1118IBA 01/2018
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 11/2017
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 11/2017
1	Proteins (Proteins, Gene)FDA Link 10/2016
1	AcidsIBA 01/2015
1	AzoxymethaneIBA 01/2015
1	alpha2 Subunit Collagen Type IIBA 01/2015
1	TubulinIBA 01/2015
1	VimentinIBA 01/2015
1	Conditioned Culture MediaIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2014
1	MacrolidesIBA 08/2014
1	Peroxidase (Myeloperoxidase)IBA 09/2013
1	alpha-DefensinsIBA 01/2013
1	Adenosine Monophosphate (AMP)IBA 01/2013
1	LactoferrinIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	HepcidinsIBA 01/2013
1	bactericidal permeability increasing proteinIBA 01/2013
1	AutoantibodiesIBA 01/2013
1	DefensinsIBA 01/2013
1	beta-DefensinsIBA 01/2013
1	AntibodiesIBA 10/2012
1	DNA (Deoxyribonucleic Acid)IBA 11/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2011
1	Bacterial DNAIBA 11/2011
1	Interleukin-8 (Interleukin 8)IBA 02/2011
1	BQ 788IBA 01/2011
1	Urea (Carbamide)FDA LinkGeneric 01/2011
1	Vasoconstrictor AgentsIBA 01/2011
1	Endothelin-1 (Endothelin 1)IBA 01/2011

Therapy/Procedure

3	Oral Administration 01/2020 - 10/2016
2	Enema (Enemas) 01/2015 - 01/2015
1	Subcutaneous Injections 01/2018
1	Intravenous Administration 01/2015
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2012
1	Transplantation 11/2011